Alumis (ALMS) Tax Provisions (2024 - 2026)
Alumis' (ALMS) quarterly Tax Provisions came in at -$1.8 million in Q2 2026, up 79.07% year-over-year from -$1.0 million in Q2 2025, and up 95.94% quarter-over-quarter from -$44.3 million in Q4 2025.
Analysis
Alumis (ALMS) Tax Provisions (2024 - 2026) Analysis & Trends
Alumis (ALMS) has reported Tax Provisions for 3 consecutive years, with -$1.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Provisions rose 79.07% year-over-year to -$1.8 million in Q2 2026; TTM through Jun 2026 was -$54.7 million, a 22.29% increase from a year earlier, with the FY2025 full-year figure at -$52.9 million, up 14.39% from the prior year.
- Tax Provisions was -$1.8 million for Q2 2026 at Alumis, up from -$44.3 million in the prior quarter.
- Over five years, Tax Provisions peaked at -$1.8 million in Q2 2026 and troughed at -$61.8 million in Q4 2024.
- A 3-year average of -$29.1 million and a median of -$26.4 million in 2025 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions gained 28.31% in 2025 and soared 79.07% in 2026, its largest moves.
- Over 3 years, Tax Provisions stood at -$61.8 million in 2024, then grew by 28.31% to -$44.3 million in 2025, then jumped by 95.94% to -$1.8 million in 2026.
- The last three Tax Provisions figures came in at -$1.8 million (Q2 2026), -$44.3 million (Q4 2025), and -$8.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Alumis | 1.27 Bn | 765.76 Mn | - | -1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Mn |
| Dec 31, 2025 | -44.30 Mn |
| Jun 30, 2025 | -8.60 Mn |
| Dec 31, 2024 | -61.79 Mn |